Iovance Biotherapeutics Q1 2026 Earnings Preview
Iovance Biotherapeutics, Inc. Common Stock · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $3.96
-16% in 7d after detection
Post-detection moves
1h
—
1d
-13%
3d
-9.5%
7d
-16%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS